Certified by Founder Lodge
Corteria Pharmaceuticals
France - Paris
START UP
1 Disclosed Funding Rounds $69,471,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Development of transformative therapies for the treatment of worsening and acute decompensated heart failure
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 07 ,2023 | Series A | $69,471,000 |
Omnes
OrbiMed
Kurma Partners
JEITO
Fountain Healthcare Partners
V-Bio Ventures
Invivo Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
